Minimize Menorrhagia in Women With Von Willebrand Disease
Recruiting
Carnegie Mellon University
Phase 3
2019-02-07
This is an outpatient, 24-week Phase III prospective, randomized, crossover trial comparing
recombinant von Willebrand factor (rVWF) and tranexamic acid (TA, Lysteda®) to minimize
menorrhagia in women with von Willebrand disease (VWD). The purpose of this Phase III
multicenter prospective, randomized, crossover arm trial is to compare recombinant von
Willebrand factor (rVWF) to tranexamic acid (TA) in reducing the severity of menorrhagia in
women with von Willebrand disease.
Minimize Menorrhagia in Women With Von Willebrand Disease
Recruiting
Duke University
Phase 3
2019-02-07
This is an outpatient, 24-week Phase III prospective, randomized, crossover trial comparing
recombinant von Willebrand factor (rVWF) and tranexamic acid (TA, Lysteda®) to minimize
menorrhagia in women with von Willebrand disease (VWD). The purpose of this Phase III
multicenter prospective, randomized, crossover arm trial is to compare recombinant von
Willebrand factor (rVWF) to tranexamic acid (TA) in reducing the severity of menorrhagia in
women with von Willebrand disease.
Minimize Menorrhagia in Women With Von Willebrand Disease
Recruiting
University of North Carolina
Phase 3
2019-02-07
This is an outpatient, 24-week Phase III prospective, randomized, crossover trial comparing
recombinant von Willebrand factor (rVWF) and tranexamic acid (TA, Lysteda®) to minimize
menorrhagia in women with von Willebrand disease (VWD). The purpose of this Phase III
multicenter prospective, randomized, crossover arm trial is to compare recombinant von
Willebrand factor (rVWF) to tranexamic acid (TA) in reducing the severity of menorrhagia in
women with von Willebrand disease.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
